Prilosec Rx Ad Spend Jumps As OTC Switch Review Approaches
This article was originally published in The Tan Sheet
Executive Summary
AstraZeneca dedicated $62.2 mil. to DTC advertising for Rx Prilosec (omeprazole) in the first six months of 2000, according to measured media spending data from Competitive Media Reporting.
You may also be interested in...
Prilosec 24-Hour Acid Control Would Be Unique To OTC Category
Once-a-day dosing of heartburn remedy Prilosec could be highlighted by AstraZeneca/Proctor & Gamble as a competitive advantage over other OTC stomach therapies if an Rx-to-OTC switch of the proton pump inhibitor were approved by FDA.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands